6/18/2014 10:05:54 AM
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today commented on Valeant Pharmaceuticals International, Inc.’s (“Valeant”) unsolicited exchange offer to acquire all outstanding common shares of Allergan. Pursuant to the Valeant exchange offer, Allergan stockholders would receive 0.83 shares of Valeant common stock and $72.00 in cash per share of common stock of the Company (the “Exchange Offer”).
Help employers find you! Check out all the jobs and post your resume.
comments powered by